For the year ending 2025-12-31, RANI has $58,621K in assets. $17,109K in debts. $18,618K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 18,618 | |||
| Accounts receivable | 2,042 | |||
| Contract asset | 0 | |||
| Marketable securities | 31,091 | |||
| Prepaid expenses and other current assets | 1,570 | |||
| Total current assets | 53,321 | |||
| Property and equipment, net | 736 | |||
| Operating lease right-of-use asset | 4,318 | |||
| Other assets | 246 | |||
| Total assets | 58,621 | |||
| Accounts payable | 309 | |||
| Accrued expenses and other current liabilities | 3,943 | |||
| Current portion of deferred revenue | 6,831 | |||
| Current portion of long-term debt | 0 | |||
| Current portion of operating lease liability | 1,586 | |||
| Total current liabilities | 12,669 | |||
| Long-term deferred revenue | 1,708 | |||
| Long-term debt, less current portion | 0 | |||
| Operating lease liability, less current portion | 2,732 | |||
| Total liabilities | 17,109 | |||
| Common stock, value-Common Class A | 9 | |||
| Common stock, value-Common Class B | 2 | |||
| Common stock, value-Common Class C | 0 | |||
| Additional paid-in capital | 165,578 | |||
| Accumulated other comprehensive gain | 1 | |||
| Accumulated deficit | -132,580 | |||
| Total stockholders' equity attributable to rani therapeutics holdings, inc | 33,010 | |||
| Non-controlling interest | 8,502 | |||
| Total stockholders' equity | 41,512 | |||
| Total liabilities and stockholders' equity | 58,621 | |||
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)